These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
501 related items for PubMed ID: 19493591
1. Synthesis and evaluation of A-seco type triterpenoids for anti-HIV-1protease activity. Wei Y, Ma CM, Hattori M. Eur J Med Chem; 2009 Oct; 44(10):4112-20. PubMed ID: 19493591 [Abstract] [Full Text] [Related]
2. Synthesis of dammarane-type triterpene derivatives and their ability to inhibit HIV and HCV proteases. Wei Y, Ma CM, Hattori M. Bioorg Med Chem; 2009 Apr 15; 17(8):3003-10. PubMed ID: 19339186 [Abstract] [Full Text] [Related]
3. Synthesis of piscidinol A derivatives and their ability to inhibit HIV-1 protease. Wei Y, Ma CM, Jiang TB, Du J, Zhou X, Liu GQ, Hattori M. J Asian Nat Prod Res; 2015 Apr 15; 17(11):1079-90. PubMed ID: 26456550 [Abstract] [Full Text] [Related]
5. Anti-HIV-1 protease triterpenoids from Stauntonia obovatifoliola Hayata subsp. intermedia. Wei Y, Ma CM, Chen DY, Hattori M. Phytochemistry; 2008 Jun 15; 69(9):1875-9. PubMed ID: 18433808 [Abstract] [Full Text] [Related]
7. Nonpeptide cyclic cyanoguanidines as HIV-1 protease inhibitors: synthesis, structure-activity relationships, and X-ray crystal structure studies. Jadhav PK, Woerner FJ, Lam PY, Hodge CN, Eyermann CJ, Man HW, Daneker WF, Bacheler LT, Rayner MM, Meek JL, Erickson-Viitanen S, Jackson DA, Calabrese JC, Schadt M, Chang CH. J Med Chem; 1998 Apr 23; 41(9):1446-55. PubMed ID: 9554878 [Abstract] [Full Text] [Related]
8. Design, asymmetric synthesis, and evaluation of pseudosymmetric sulfoximine inhibitors against HIV-1 protease. Lu D, Sham YY, Vince R. Bioorg Med Chem; 2010 Mar 01; 18(5):2037-48. PubMed ID: 20138769 [Abstract] [Full Text] [Related]
9. Cyclic HIV-1 protease inhibitors derived from mannitol: synthesis, inhibitory potencies, and computational predictions of binding affinities. Hultén J, Bonham NM, Nillroth U, Hansson T, Zuccarello G, Bouzide A, Aqvist J, Classon B, Danielson UH, Karlén A, Kvarnström I, Samuelsson B, Hallberg A. J Med Chem; 1997 Mar 14; 40(6):885-97. PubMed ID: 9083477 [Abstract] [Full Text] [Related]
10. Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents. Sun IC, Wang HK, Kashiwada Y, Shen JK, Cosentino LM, Chen CH, Yang LM, Lee KH. J Med Chem; 1998 Nov 05; 41(23):4648-57. PubMed ID: 9804704 [Abstract] [Full Text] [Related]
11. Novel arylsulfonamides possessing sub-picomolar HIV protease activities and potent anti-HIV activity against wild-type and drug-resistant viral strains. Miller JF, Furfine ES, Hanlon MH, Hazen RJ, Ray JA, Robinson L, Samano V, Spaltenstein A. Bioorg Med Chem Lett; 2004 Feb 23; 14(4):959-63. PubMed ID: 15013001 [Abstract] [Full Text] [Related]
12. Anti-HIV-1 protease activity of lanostane triterpenes from the vietnamese mushroom Ganoderma colossum. El Dine RS, El Halawany AM, Ma CM, Hattori M. J Nat Prod; 2008 Jun 23; 71(6):1022-6. PubMed ID: 18547117 [Abstract] [Full Text] [Related]
19. Lysine derivatives as potent HIV protease inhibitors. Discovery, synthesis and structure-activity relationship studies. Bouzide A, Sauvé G, Yelle J. Bioorg Med Chem Lett; 2005 Mar 01; 15(5):1509-13. PubMed ID: 15713418 [Abstract] [Full Text] [Related]